Cargando…
Clinical utility of the pan-immune-inflammation value in breast cancer patients
BACKGROUND: The newly discovered pan-immune-inflammation value (PIV) has been illustrated to have good prognostic value for cancer patient prognosis. However, the prognostic usefulness of PIV in breast cancer patients is unknown. As a result, to aid the clinic in providing a distinctive and trustwor...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499041/ https://www.ncbi.nlm.nih.gov/pubmed/37711203 http://dx.doi.org/10.3389/fonc.2023.1223786 |